Boris Engels

3.7k total citations
36 papers, 1.6k citations indexed

About

Boris Engels is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Boris Engels has authored 36 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 23 papers in Immunology and 9 papers in Genetics. Recurrent topics in Boris Engels's work include CAR-T cell therapy research (28 papers), Immunotherapy and Immune Responses (12 papers) and Immune Cell Function and Interaction (12 papers). Boris Engels is often cited by papers focused on CAR-T cell therapy research (28 papers), Immunotherapy and Immune Responses (12 papers) and Immune Cell Function and Interaction (12 papers). Boris Engels collaborates with scholars based in United States, Germany and Switzerland. Boris Engels's co-authors include Wolfgang Uckert, Hans Schreiber, Donald A. Rowley, Thomas Blankenstein, David M. Kranz, Matthias Leisegang, Hans J. Stauss, Shao‐An Xue, David C. Binder and Hakan Çam and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Boris Engels

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris Engels United States 21 1.2k 886 480 387 153 36 1.6k
Xiao‐Tong Song United States 17 1.0k 0.8× 644 0.7× 391 0.8× 491 1.3× 206 1.3× 47 1.5k
Junichi Mineno Japan 21 1.1k 0.9× 896 1.0× 517 1.1× 744 1.9× 155 1.0× 72 1.8k
Megan M. Suhoski United States 18 1.5k 1.2× 1.4k 1.6× 507 1.1× 506 1.3× 298 1.9× 22 2.3k
Connie P.M. Duong United States 15 1.1k 0.9× 683 0.8× 313 0.7× 379 1.0× 259 1.7× 24 1.4k
Linjie Guo United States 13 930 0.8× 749 0.8× 248 0.5× 348 0.9× 193 1.3× 24 1.4k
Azam Nahvi Iran 7 2.3k 1.8× 1.7k 2.0× 807 1.7× 670 1.7× 277 1.8× 26 2.7k
Ralph A. Willemsen Netherlands 21 1.5k 1.2× 1.1k 1.2× 732 1.5× 483 1.2× 192 1.3× 33 1.8k
Ignazio Caruana Italy 18 1.4k 1.1× 709 0.8× 496 1.0× 556 1.4× 488 3.2× 35 1.8k
Jean‐Baptiste Latouche France 20 1.6k 1.3× 1.2k 1.4× 542 1.1× 679 1.8× 301 2.0× 47 2.3k
Hollie J. Pegram United States 16 1.6k 1.3× 1.1k 1.3× 470 1.0× 467 1.2× 429 2.8× 20 2.1k

Countries citing papers authored by Boris Engels

Since Specialization
Citations

This map shows the geographic impact of Boris Engels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Engels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Engels more than expected).

Fields of papers citing papers by Boris Engels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris Engels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Engels. The network helps show where Boris Engels may publish in the future.

Co-authorship network of co-authors of Boris Engels

This figure shows the co-authorship network connecting the top 25 collaborators of Boris Engels. A scholar is included among the top collaborators of Boris Engels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris Engels. Boris Engels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Engels, Boris, Poh Yin Yew, Kazuma Kiyotani, et al.. (2024). One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication. Clinical Cancer Research. 30(8). 1642–1654. 11 indexed citations
4.
Engels, Boris, Andrew Price, Andrew M. Stein, et al.. (2021). Preservation of T-Cell Stemness with a Novel Expansionless CAR-T Manufacturing Process, Which Reduces Manufacturing Time to Less Than Two Days, Drives Enhanced CAR-T Cell Efficacy. Blood. 138(Supplement 1). 2848–2848. 19 indexed citations
5.
6.
Watanabe, Keisuke, Yanping Luo, Tong Da, et al.. (2018). Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 3(7). 215 indexed citations
7.
Leisegang, Matthias, Boris Engels, Karin Schreiber, et al.. (2015). Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation. Clinical Cancer Research. 22(11). 2734–2743. 59 indexed citations
8.
Binder, David C., Boris Engels, Ainhoa Arina, et al.. (2013). Antigen-Specific Bacterial Vaccine Combined with Anti-PD-L1 Rescues Dysfunctional Endogenous T Cells to Reject Long-Established Cancer. Cancer Immunology Research. 1(2). 123–133. 65 indexed citations
9.
Engels, Boris, Víctor H. Engelhard, John Sidney, et al.. (2013). Relapse or Eradication of Cancer Is Predicted by Peptide-Major Histocompatibility Complex Affinity. Cancer Cell. 23(4). 516–526. 121 indexed citations
10.
Liu, Rebecca B., Boris Engels, Ainhoa Arina, et al.. (2012). Densely Granulated Murine NK Cells Eradicate Large Solid Tumors. Cancer Research. 72(8). 1964–1974. 45 indexed citations
11.
Schreiber, Karin, Ainhoa Arina, Boris Engels, et al.. (2012). Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers. Clinical Cancer Research. 18(9). 2526–2533. 21 indexed citations
12.
Chervin, Adam S., Jennifer D. Stone, Boris Engels, et al.. (2012). Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses. Gene Therapy. 20(6). 634–644. 18 indexed citations
13.
Aggen, David H., Adam S. Chervin, Thomas M. Schmitt, et al.. (2011). Single-chain VαVβ T-cell receptors function without mispairing with endogenous TCR chains. Gene Therapy. 19(4). 365–374. 42 indexed citations
14.
Engels, Boris, Donald A. Rowley, & Hans Schreiber. (2011). Targeting stroma to treat cancers. Seminars in Cancer Biology. 22(1). 41–49. 62 indexed citations
15.
Leisegang, Matthias, Adriana Turqueti‐Neves, Boris Engels, et al.. (2010). T-Cell Receptor Gene–Modified T Cells with Shared Renal Cell Carcinoma Specificity for Adoptive T-Cell Therapy. Clinical Cancer Research. 16(8). 2333–2343. 26 indexed citations
16.
Höpken, Uta E., Jana Wolf, Hans‐Willi Mittrücker, et al.. (2009). The tumor-associated antigen EBAG9 negatively regulates the cytolytic capacity of mouse CD8+ T cells. Journal of Clinical Investigation. 119(8). 2184–203. 18 indexed citations
17.
Leisegang, Matthias, Boris Engels, Elisa Kieback, et al.. (2008). Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. Journal of Molecular Medicine. 86(7). 855–855. 5 indexed citations
18.
Leisegang, Matthias, Boris Engels, Elisa Kieback, et al.. (2008). Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette. Journal of Molecular Medicine. 86(5). 573–583. 99 indexed citations
19.
Engels, Boris & Wolfgang Uckert. (2007). Redirecting T lymphocyte specificity by T cell receptor gene transfer – A new era for immunotherapy. Molecular Aspects of Medicine. 28(1). 115–142. 38 indexed citations
20.
Klinkert, Mo‐Quen, Francesca Bugli, Jose Cruz, Boris Engels, & Donato Cioli. (1996). Sequence conservation of schistosome cyclophilins. Molecular and Biochemical Parasitology. 81(2). 239–242. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiao‐Tong Song Breakdown of academic impact, for papers by Junichi Mineno Breakdown of academic impact, for papers by Megan M. Suhoski Breakdown of academic impact, for papers by Connie P.M. Duong Breakdown of academic impact, for papers by Linjie Guo Breakdown of academic impact, for papers by Azam Nahvi Breakdown of academic impact, for papers by Ralph A. Willemsen Breakdown of academic impact, for papers by Ignazio Caruana Breakdown of academic impact, for papers by Jean‐Baptiste Latouche Breakdown of academic impact, for papers by Hollie J. Pegram
Rankless by CCL
2026